Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Budesonide Rectal Foam vs Uceris
NCT02800824Phase 1Completed
- Sponsor
- Padagis
- Primary completion
- Jun 2016
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of budesonide in ulcerative colitis (UC) (2 arms), sponsored by Padagis. Primary endpoints: Maximum observed plasma drug concentration at 24 hours, Area under the concentration-time curve from time 0 extrapolated to infinity at 24 hours and 1 more. Status: completed.
02
Drugs
budesonide
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02800824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02800824.